Copper Peptide GHK-Cu vs Lanreotide
Overview
Copper Peptide GHK-Cu is primarily a cosmetic & skin peptide, while Lanreotide is used for hormonal.
This page compares Copper Peptide GHK-Cu and Lanreotide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Copper Peptide GHK-Cu | Lanreotide | |
|---|---|---|
| Category | Cosmetic & Skin | Hormonal |
| Regulatory status (US) | Compounding (Rx) — Apr 2026 | FDA approved |
| Typical dosage | Topical or injectable | 60-120 mg |
| Frequency | daily | every 4 weeks |
| Reported benefits | Skin regeneration, collagen, wound healing, hair growth | suppression of excess growth hormone and IGF-1 in acromegaly, improved progression-free survival in GEP-NETs, reduction of carcinoid syndrome symptoms, inhibition of multiple GI and pancreatic hormones |
| Reported side effects | Safe both topical and injectable | diarrhea, cholelithiasis, abdominal pain, hyperglycemia, bradycardia, injection site reactions, nausea, hypertension, headache, thyroid function decreases |
Key differences
Primary use. Copper Peptide GHK-Cu is categorised under Cosmetic & Skin, while Lanreotide falls under Hormonal. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Copper Peptide GHK-Cu: not FDA-approved; compounding permitted with a prescription as of April 2026. Lanreotide: FDA-approved.
Dosing. Copper Peptide GHK-Cu is typically dosed at Topical or injectable (daily). Lanreotide is typically dosed at 60-120 mg (every 4 weeks).
Can you stack them?
Some protocols combine peptides, but stacking Copper Peptide GHK-Cu and Lanreotide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Copper Peptide GHK-Cu and Lanreotide?
- Copper Peptide GHK-Cu is primarily a cosmetic & skin peptide, while Lanreotide is used for hormonal. Copper Peptide GHK-Cu is not FDA-approved; compounding permitted with a prescription (as of April 2026), whereas Lanreotide is FDA-approved for one or more indications.
- What is Copper Peptide GHK-Cu used for?
- Multi-functional skin peptide.
- What is Lanreotide used for?
- FDA-approved long-acting somatostatin analog for acromegaly, GEP-NETs, and carcinoid syndrome.
- Can you take Copper Peptide GHK-Cu and Lanreotide together?
- Some users combine peptides within a single protocol, but stacking Copper Peptide GHK-Cu and Lanreotide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Copper Peptide GHK-Cu or Lanreotide FDA-approved?
- Copper Peptide GHK-Cu is not FDA-approved; compounding permitted with a prescription (as of April 2026). Lanreotide is FDA-approved for one or more indications.
Read the full articles
- Copper Peptide GHK-Cu — full monograph: mechanism, research, dosing & references
- Lanreotide — full monograph: mechanism, research, dosing & references